Formation Bio Announces $600 Million Debut Fund to Expand Drug Development Capacity

Formation Bio Drug Development Accelerator Fund pairs dedicated capital with the company's AI-native development platform to scale its portfolio of clinical-stage medicines

PR Newswire Business Technology · 2026-10-28T14:00:00.000Z